Ensaio com inibidor da colinesterase para prevenir quedas na doença de Parkinson (CHIEF-PD): um ensaio randomizado de fase 3, duplo-cego, controlado por placebo de rivastigmina para prevenir quedas na doença de Parkinson

 29 October 2021 - Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease.